Musculoskeletal manifestations of systemic disease

Textbook of Pediatric Rheumatology

Volumn , Issue , 2005, Pages 630-641

  Cassidy, James T ^a,b   Petty, Ross E ^c  

^a University of Missouri   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953833477     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-0246-8.50038-3     Document Type: Chapter

References (134)

1. Mankin HJ, Mankin CJ Metabolic bone disease: an update. Instr Course Lect 2003, 52:769-784.
2. The Metabolic and Molecular Bases of Inherited Disease 1995, McGraw-Hill, New York. 7th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
3. Abrams SA Nutritional rickets: an old disease returns. Nutr Rev 2002, 60:111-115.
4. Wharton B, Bishop N Rickets. Lancet 2003, 362:1389-1400.
5. Mishra S, Yadav TP, Nangia S, et al. Vitamin D-dependent rickets type II. Indian Pediatr 1996, 33:334-336.
6. Holick MF Vitamin D: A millennium perspective. J Cell Biochem 2003, 88:296-307.
7. Ono T, Seino Y Medical management and complications of X-linked hypophosphatemic vitamin D resistant rickets. Acta Paediatr Jpn 1997, 39:503-507.
8. Sultan A, Vitale P Vitamin D-dependent rickets type II with alopecia: two case reports and review of the literature. Int J Dermatol 2003, 42:682-685.
9. Sato S, Matsuo N Genetic analysis of hypophosphatasia. Acta Paediatr Jpn 1997, 39:528-532.
10. Jacob RA Three eras of vitamin C discovery. Subcell Biochem 1996, 25:1-16.
11. Ratanachu-Ek S, Sukswai P, Jeerathanyasakun Y, et al. Scurvy in pediatric patients: a review of 28 cases. J Med Assoc Thai 2003, 86(Suppl 3):S734-S740.
12. Perrotta S, Nobili B, Rossi F, et al. Vitamin A and infancy. Biochemical, functional, and clinical aspects. Vitam Horm 2003, 66:457-591.
13. Pease CN Focal retardation and arrestment of growth of bones due to vitamin A intoxication. JAMA 1962, 182:980-985.
14. Christensen WR, Liebman C, Sosman MC Skeletal and periarticular manifestations of hypervitaminosis D. Am J Roentgenol Radium Ther Nucl Med 1951, 65:27-41.
15. Barot VV Occurrence of endemic fluorosis in human population of North Gujarat, India: human health risk. Bull Environ Contam Toxicol 1998, 61:303-310.
16. Levy SM An update on fluorides and fluorosis. J Can Dent Assoc 2003, 69:286-291.
17. Fisher RL, Medcalf TW, Henderson MC Endemic fluorosis with spinal cord compression. A case report and review. Arch Intern Med 1989, 149:697-700.
18. Nesterov AI The clinical course of Kashin-Beck disease. Arthritis Rheum 1964, 26:29-40.
19. Takamori T Kashin-Beck's disease 1968, University School of Medicine, The Professor Tokio Takamori Foundation, Tokyo.
20. Sokoloff L Endemic forms of osteoarthritis. Clin Rheum Dis 1985, 11:187-202.
21. Lee YW, Mirocha CJ, Shroeder DJ, et al. TDP-1, a toxic component causing tibial dyschondroplasia in broiler chickens, and trichothecenes from Fusarium roseum 'Graminearum.'. Appl Environ Microbiol 1985, 50:102-107.
22. Sokoloff L Kashin-Beck disease. Rheum Dis Clin North Am 1987, 13:101-104.
23. Tomlinson R Beijing conference reviews Kashin-Beck disease. BMJ 1999, 318:485.
24. Zhang WH, Neve J, Xu JP, et al. Selenium, iodine and fungal contamination in Yulin District (People's Republic of China) endemic for Kashin-Beck disease. Int Orthop 2001, 25:188-190.
25. Suetens C, Moreno-Reyes R, Chasseur C, et al. Epidemiological support for a multifactorial aetiology of Kashin-Beck disease in Tibet. Int Orthop 2001, 25:180-187.
26. Moreno-Reyes R, Mathieu F, Boelaert M, et al. Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy. Am J Clin Nutr 2003, 78:137-144.
27. Pasteels JL, Liu FD, Hinsenkamp M, et al. Histology of Kashin-Beck lesions. Int Orthop 2001, 25:151-153.
28. Mathieu F, Begaux F, Lan ZY, et al. Clinical manifestations of Kashin-Beck disease in Nyemo Valley, Tibet. Int Orthop 1997, 21:151-156.
29. Xiong G Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi Province, PR China. Int Orthop 2001, 25:147-150.
30. Yu W, Wang Y, Jiang Y, et al. Kashin-Beck disease in children: radiographic findings in the wrist. Skeletal Radiol 2002, 31:222-225.
31. Lockitch G, Fellingham SA, Wittman W, et al. Mseleni joint disease: the pilot clinical survey. S Afr Med J 1973, 47:2283-2293.
32. Lockitch G, Fellingham SA, Elphinstone CD Mseleni joint disease: a radiological study of two affected families. S Afr Med J 1973, 47:2366-2376.
33. Rodriguez-Merchan EC Effects of hemophilia on articulations of children and adults. Clin Orthop 1996, 7-13.
34. Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000, 342:83-89.
35. Becker MA Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout). Rheum Dis Clin North Am 1988, 14:377-394.
36. Simkin PA Gout and hyperuricemia. Curr Opin Rheumatol 1997, 9:268-273.
37. Agudelo CA, Wise CM Crystal-associated arthritis. Clin Geriatr Med 1998, 14:495-513.
38. Wortmann RL Effective management of gout: an analogy. Am J Med 1998, 105:513-514.
39. Emmerson BT The management of gout. N Engl J Med 1996, 334:445-451.
40. Treadwell BL Juvenile gout. Ann Rheum Dis 1971, 30:279-284.
41. Liberman UA, Samuel R, Halabe A, et al. Juvenile metabolic gout caused by chronic compensated hemolytic syndrome. Arthritis Rheum 1982, 25:1264-1266.
42. Yarom A, Rennebohm RM, Strife F, et al. Juvenile gouty arthritis. Two cases associated with mild renal insufficiency. Am J Dis Child 1984, 138:955-957.
43. Hoyningen-Huene CB Gout and glycogen storage disease in preadolescent brothers. Arch Intern Med 1966, 118:471-477.
44. Morley CJ, Houston IB, Morris-Jones P Acute renal failure and gout as presenting features of acute lymphoblastic leukaemia. Arch Dis Child 1976, 51:723-725.
45. Warren DJ, Simmonds HA, Gibson T, et al. Familial gout and renal failure. Arch Dis Child 1981, 56:699-704.
46. Calabrese G, Simmonds HA, Cameron JS, et al. Precocious familial gout with reduced fractional urate clearance and normal purine enzymes. Q J Med 1990, 75:441-450.
47. Foreman JW, Yudkoff M Familial hyperuricemia and renal insufficiency. Child Nephrol Urol 1990, 10:115-118.
48. Lesch M, Nyhan WL A familial disorder of uric acid metabolism and central nervous system function. Am J Med 1964, 36:561-570.
49. Seegmiller JE, Rosenbloom FM, Kelley WN Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science 1967, 155:1682-1684.
50. Kelley WN, Greene ML, Rosenbloom FM, et al. Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout. Ann Intern Med 1969, 70:155-206.
51. Nyhan WL The recognition of Lesch-Nyhan syndrome as an inborn error of purine metabolism. J Inherit Metab Dis 1997, 20:171-178.
52. Becker MA, Puig JG, Mateos FA, et al. Inherited superactivity of phosphori-bosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness. Am J Med 1988, 85:383-390.
53. Ahmed M, Taylor W, Smith PR, et al. Accelerated transcription of PRPS1 in X-linked overactivity of normal human phosphoribosylpyrophosphate synthetase. J Biol Chem 1999, 274:7482-7488.
54. Alepa FP, Howell RR, Klinenberg JR, et al. Relationships between glycogen storage disease and tophaceous gout. Am J Med 1967, 42:58-66.
55. Chou JY, Matern D, Mansfield BC, et al. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med 2002, 2:121-143.
56. Rosenthal AK Calcium crystal-associated arthritides. Curr Opin Rheumatol 1998, 10:273-277.
57. Reginato AJ, Reginato AM Diseases associated with deposition of calcium pyrophosphate or hydroxyapolite. Kelley's Textbook of Rheumatology 2000, 1377-1390. WB Saunders, Philadelphia. 6th ed. S. Ruddy, E.D. Harris, C.B. Sledge (Eds.).
58. Steinbach LS, Resnick D Calcium pyrophosphate dihydrate crystal deposition disease revisited. Radiology 1996, 200:1-9.
59. Richardson BC, Chafetz NI, Ferrell LD, et al. Hereditary chondrocalcinosis in a Mexican-American family. Arthritis Rheum 1983, 26:1387-1396.
60. O'Brien WM, LaDu BN, Bunim JJ Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy. Review of the world literature (1584-1962). Am J Med 1963, 34:813.
61. Dom K, Pittevils T Ochronotic arthropathy: the black hip. Case report and review of the literature. Acta Orthop Belg 1997, 63:122-125.
62. Davignon J, Genest J Genetics of lipoprotein disorders. Endocrinol Metab Clin North Am 1998, 27:521-550.
63. Franklin FA, Dashti N, Franklin CC Evaluation and management of dys-lipoproteinemia in children. Endocrinol Metab Clin North Am 1998, 27:641-654.
64. Cleeman JI Detection and evaluation of dyslipoproteinemia. Endocrinol Metab Clin North Am 1998, 27:597-611. ix.
65. Shapiro JR, Fallat RW, Tsang RC, et al. Achilles tendinitis and tenosynovitis. A diagnostic manifestation of familial type II hyperlipoproteinemia in children. Am J Dis Child 1974, 128:486-490.
66. Ose L Familial hypercholesterolemia from children to adults. Cardiovasc Drugs Ther 2002, 16:289-293.
67. Buckingham RB, Bole GG, Bassett DR Polyarthritis associated with type IV hyperlipoproteinemia. Arch Intern Med 1975, 135:286-290.
68. Belamarich PF, Deckelbaum RJ, Starc TJ, et al. Response to diet and cholestyramine in a patient with sitosterolemia. Pediatrics 1990, 86:977-981.
69. Björkem I, Boberg KM Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. The Metabolic and Molecular Bases of Inherited Disease 1995, 2073-2102. McGraw-Hill, New York. 7th ed. C.S. Scriver, A.L. Beaudet, W.S. Sly (Eds.).
70. Weinberg AG, Currarino G Sickle cell dactylitis: histopathologic observations. Am J Clin Pathol 1972, 58:518-523.
71. Fixler J, Styles L Sickle cell disease. Pediatr Clin North Am 2002, 49:1193-1210. vi.
72. Gerster JC, Dardel R, Guggi S Recurrent episodes of arthritis in thalassemia minor. J Rheumatol 1984, 11:352-354.
73. Arman MI, Butun B, Doseyen A, et al. Frequency and features of rheumatic findings in thalassaemia minor: a blind controlled study. Br J Rheumatol 1992, 31:197-199.
74. Lo L, Singer ST Thalassemia: current approach to an old disease. Pediatr Clin North Am 2002, 49:1165-1191.
75. Jean-Baptiste G, De Ceulaer K Osteoarticular disorders of haematological origin. Baillieres Best Pract Res Clin Rheumatol 2000, 14:307-323.
76. Lane PA Sickle cell disease. Pediatr Clin North Am 1996, 43:639-664.
77. Gilbert MS, Radomisli TE Therapeutic options in the management of hemophilic synovitis. Clin Orthop 1997, 343:88-92.
78. Rifai A, Nyman R Scintigraphy and ultrasonography in differentiating osteomyelitis from bone infarction in sickle cell disease. Acta Radiol 1997, 38:139-143.
79. Vichinsky EP The morbidity of bone disease in thalassemia. Ann N Y Acad Sci 1998, 850:344-348.
80. Ljung R Paediatric care of the child with haemophilia. Haemophilia 2002, 8:178-182.
81. Arnold WD, Hilgartner MW Hemophilic arthropathy. Current concepts of pathogenesis and management. J Bone Joint Surg Am 1977, 59:287-305.
82. Ahlberg A, Silwer J Arthropathy in von Willebrand's disease. Acta Orthop Scand 1970, 41:539-544.
83. Ljung RC Can haemophilic arthropathy be prevented?. Br J Haematol 1998, 101:215-219.
84. Alcalay M, Deplas A Rheumatological management of patients with hemophilia. Part II: Muscle hematomas and pseudotumors. Joint Bone Spine 2002, 69:556-559.
85. Rodriguez-Merchan EC Management of musculoskeletal complications of hemophilia. Semin Thromb Hemost 2003, 29:87-96.
86. Handelsman JE The knee joint in hemophilia. Orthop Clin North Am 1979, 10:139-173.
87. Buzzard BM Physiotherapy for the prevention of articular contraction in haemophilia. Haemophilia 1999, 5(Suppl 1):10-15.
88. Gruppo RA, Brown D, Wilkes MM, et al. Comparative effectiveness of full-length and B-domain deleted factor VIII for prophylaxis-a meta-analysis. Haemophilia 2003, 9:251-260.
89. Kisker CT, Burke C Double-blind studies on the use of steroids in the treatment of acute hemarthrosis in patients with hemophilia. N Engl J Med 1970, 282:639-642.
90. Hilgartner MW Current treatment of hemophilic arthropathy. Curr Opin Pediatr 2002, 14:46-49.
91. Journeycake JM, Miller KL, Anderson AM, et al. Arthroscopic synovectomy in children and adolescents with hemophilia. J Pediatr Hematol Oncol 2003, 25:726-731.
92. Grgic A, Rosenbloom AL, Weber FT, et al. Joint contracture-common manifestation of childhood diabetes mellitus. J Pediatr 1976, 88:584-588.
93. Buckingham BA, Uitto J, Sandborg C, et al. Scleroderma-like syndrome and the non-enzymatic glucosylation of collagen in children with poorly controlled insulin dependent diabetes. Pediatr Res 1981, 15:626.
94. Rudolf MC, Genel M, Tamborlane WV, et al. Juvenile rheumatoid arthritis in children with diabetes mellitus. J Pediatr 1981, 99:519-524.
95. Rosenbloom AL, Silverstein JH, Lezotte DC, et al. Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease. N Engl J Med 1981, 305:191-194.
96. Vijanto JA Dupuytren's contracture: a review. Semin Arthritis Rheum 1973, 3:155-176.
97. de Seze S, Solnica J, Mitrovic D, et al. Joint and bone disorders and hypoparathyroidism in hemochromatosis. Semin Arthritis Rheum 1972, 2:71-94.
98. De Gobbi M, Roetto A, Piperno A, et al. Natural history of juvenile haemochromatosis. Br J Haematol 2002, 117:973-979.
99. Camaschella C, Roetto A, De Gobbi M Juvenile hemochromatosis. Semin Hematol 2002, 39:242-248.
100. Clouse ME, Gramm HF, Legg M, et al. Diabetic osteoarthropathy. Clinical and roentgenographic observations in 90 cases. Am J Roentgenol Radium Ther Nucl Med 1974, 121:22-34.
101. Mazzuoli GF, D'Erasmo E, Pisani D Primary hyperparathyroidism and osteoporosis. Aging (Milano) 1998, 10:225-231.
102. Bhalla AK Musculoskeletal manifestations of primary hyperparathyroidism. Clin Rheum Dis 1986, 12:691-705.
103. Eberhard BA, Laxer RM, Eddy AA, et al. Presence of thyroid abnormalities in children with systemic lupus erythematosus. J Pediatr 1991, 119:277-279.
104. Kinsella RA, Back DK Thyroid acropachy. Med Clin North Am 1968, 52:393-398.
105. Botton E, Saraux A, Laselve H, et al. Musculoskeletal manifestations in cystic fibrosis. Joint Bone Spine 2003, 70:327-335.
106. Athreya BH, Borns P, Rosenlund ML Cystic fibrosis and hypertrophic osteoarthropathy in children. Report of three cases. Am J Dis Child 1975, 129:634-637.
107. Nathanson I, Riddlesberger MM Pulmonary hypertrophic osteoarthropathy in cystic fibrosis. Radiology 1980, 135:649-651.
108. Sagransky DM, Greenwald RA, Gorvoy JD Seropositive rheumatoid arthritis in a patient with cystic fibrosis. Am J Dis Child 1980, 134:319-320.
109. Newman AJ, Ansell BM Episodic arthritis in children with cystic fibrosis. J Pediatr 1979, 94:594-596.
110. Schidlow DV, Goldsmith DP, Palmer J, et al. Arthritis in cystic fibrosis. Arch Dis Child 1984, 59:377-379.
111. Dixey J, Redington AN, Butler RC, et al. The arthropathy of cystic fibrosis. Ann Rheum Dis 1988, 47:218-223.
112. Pertuiset E, Menkes CJ, Lenoir G, et al. Cystic fibrosis arthritis. A report of five cases. Br J Rheumatol 1992, 31:535-538.
113. Warren RW Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones. Pediatr Infect Dis J 1997, 16:118-122.
114. Soden M, Tempany E, Bresnihan B Sarcoid arthropathy in cystic fibrosis. Br J Rheumatol 1989, 28:341-343.
115. Goldbloom RB, Stein PB, Eisen A, et al. Idiopathic periosteal hyperostosis with dysproteinemia. A new clinical entity. N Engl J Med 1966, 28:873.
116. Kuwashima S, Nishimura G, Harigaya A, et al. A young infant with Goldbloom syndrome. Pediatr Int 1999, 41:110-112.
117. Grossfeld SL, Van Heest A, Arendt E, et al. Pitcher's periostitis. A case report. Am J Sports Med 1998, 26:303-307.
118. Craver RD, Correa-Gracian H, Heinrich S Florid reactive periostitis. Hum Pathol 1997, 28:745-747.
119. Sinha GP, Curtis P, Haigh D, et al. Pachydermoperiostosis in childhood. Br J Rheumatol 1997, 36:1224-1227.
120. Loredo R, Pathria MN, Salonen D, et al. Magnetic resonance imaging in pachydermoperiostosis. Clin Imaging 1996, 20:212-218.
121. Shackelford PG Osseous lesions and pancreatitis. Am J Dis Child 1977, 131:731-732.
122. Goluboff N, Cram R, Ramgotra B, et al. Polyarthritis and bone lesions complicating traumatic pancreatitis in two children. Can Med Assoc J 1978, 118:924-928.
123. Buntain WL, Wood JB, Woolley MM Pancreatitis in childhood. J Pediatr Surg 1978, 13:143-149.
124. Lopez A, Garcia-Estan J, Marras C, et al. Pancreatitis associated with pleural-mediastinal pseudocyst, panniculitis and polyarthritis. Clin Rheumatol 1998, 17:335-339.
125. Alegre VA, Winkelmann RK Histiocytic cytophagic panniculitis. J Am Acad Dermatol 1989, 20:177-185.
126. Schneider JW, Jordaan HF, Geiger DH, et al. Erythema induratum of Bazin. A clinicopathological study of 20 cases and detection of Mycobacterium tuberculosis DNA in skin lesions by polymerase chain reaction. Am J Dermatopathol 1995, 17:350-356.
127. Smith KC, Pittelkow MR, Su WP Panniculitis associated with severe alpha 1-antitrypsin deficiency. Treatment and review of the literature. Arch Dermatol 1987, 123:1655-1661.
128. White JW, Winkelmann RK Weber-Christian panniculitis: a review of 30 cases with this diagnosis. J Am Acad Dermatol 1998, 39:56-62.
129. Kolter T, Sandhoff K Recent advances in the biochemistry of sphingolipi-doses. Brain Pathol 1998, 8:79-100.
130. Farber S, Cohen J, Uzman LL Lipogranulomatosis; a new lipo-glycoprotein storage disease. J Mt Sinai Hosp N Y 1957, 24:816-837.
131. Toppet M, Vamos-Hurwitz E, Jonniaux G, et al. Farber's disease as a cerami-dosis: clinical, radiological and biochemical aspects. Acta Paediatr Scand 1978, 67:113-119.
132. Brady RO Therapy for the sphingolipidoses. Arch Neurol 1998, 55:1055-1056.
133. Zayid I, Farraj S Familial histiocytic dermatoarthritis. A new syndrome. Am J Med 1973, 54:793-800.
134. Uhl M, Gutfleisch J, Rother E, et al. Multicentric reticulohistiocytosis. A report of 3 cases and review of literature. Bildgebung 1996, 63:126-129.